18 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
us to manufacture both commercial and clinical autologous drug products in the facility. The Nucleus provides multiple clean rooms, QC labs, warehouse
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
13 Feb 24
Regulation FD Disclosure
4:06pm
+ batches per year Target vein to delivery time 16 days at launch Nov 8, 2021 Groundbreaking Nov 25, 2022 First clean room operational May 2023 Capacity
8-K
EX-1.1
AUTL
Autolus Therapeutics plc
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
subsidiaries and (D) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
subsidiaries and (D) there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation
10-Q
2023 Q3
EX-10.1
AUTL
Autolus Therapeutics plc
9 Nov 23
Quarterly report
4:18pm
, on the Property. 4.5 Repairs and other works The Tenant shall: 4.5.1 keep the Property in good and substantial repair and condition and clean and tidy
6-K
EX-99.1
y9e 6jqo4w
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
hxlzz
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
ppscjx
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1.1
fu32zx
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K/A
EX-99.2
k0jeftkgphkgnu1we5le
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.3
dt57zfm
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
dnibl53 aps8ech5
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.1
qqgnpw
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1.1
zlo3za1 uguw
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
yclty1huw3 0xc1
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am
CORRESP
uzjzjlaodez76jlet4
19 Jun 18
Correspondence with SEC
12:00am
CORRESP
a9rsl1xz2w7rx797d3g
8 Jun 18
Correspondence with SEC
12:00am
CORRESP
zcy 5ifx86cb
10 May 18
Correspondence with SEC
12:00am
- Prev
- 1
- Next